Abstract: A component for a vehicle interior is disclosed; a method for producing the component is also disclosed. The component comprises a base and a cover comprising an exterior surface providing the visible surface and an interior surface; the visible surface at the cover may comprise a display operated by light source/panel configured to present an image at an image presentation area. The image presentation area may comprise a formed image presentation area; the formed image presentation area may comprise at least one formed hole formation segment comprising at least one formed hole formation based on a hole pattern segment for a pattern image area. The image presentation area of the cover may comprise each formed hole formation comprising formed hole formation segments; each formed hole formation may comprise an opening through the cover generally corresponding to a hole of the hole pattern segment.

Abstract: The present disclosure relates to a medical tissue adhesive for pancreatic plugging and the preparation method and use thereof. The medical tissue adhesive composition forming the medical tissue adhesive of the present disclosure comprises a medical tissue adhesive component and a chelating agent component; wherein the medical tissue adhesive component comprises a first component and a second component, the first component comprises four-arm polyethylene glycol amine, and the second component comprises four-arm-polyethylene glycol-succinimidyl glutarate; wherein m and n are natural numbers; and the chelating agent component comprises polyphenol. The medical tissue adhesive prepared from the medical tissue adhesive composition of the present disclosure is capable of firmly binding to the surface of the pancreatic tissue, and is capable of withstanding the dynamic pressure as a result of pancreatic juice leakage and the enzymatic degradation activity of pancreatic juice.

Abstract: Disclosed are an ice-making assembly and an ice-making device. Wherein, the ice-making assembly includes a barrel, a mount, an ice-extruding member, an ice-scraping member and a temperature control member. An ice-making chamber is formed in the barrel. The ice-scraping member is assembled in the ice-making chamber and includes a spindle, a support structure arranged on the spindle, and a receiving cavity extending in an axial direction of the spindle. The ice-scraping member is driven by a driving device to rotate with respect to the barrel. The temperature control member is assembled in the receiving cavity. The mount is assembled at a lower end of the barrel. The ice-extruding member is assembled at an upper end of the barrel. Wherein, a cross-sectional area, perpendicular to an axial direction of the spindle, of the spindle of the ice-scraping member increases gradually in a direction close to the mount.

Abstract: A display method includes obtaining an interactive operation and an operation parameter for a first object displayed in a naked-eye 3D state. The operation parameter characterizes the interactive operation. The method further includes displaying a second object in response to the operation parameter satisfying a target condition, obtaining position information related to the first object in response to the interactive operation, and controlling a display state of the second object based on the position information.

Abstract: The present disclosure pertains to the field of biomedical materials, and in particular relates to a medical hydrogel, a preparation method and uses thereof, and a kit for preparing the medical hydrogel. The medical hydrogel of the present disclosure comprises a hydrogel skeleton, and a chelating agent chelated to the hydrogel skeleton; wherein the hydrogel skeleton comprises a polymer that is formed by the bonding of a polyethylene glycol derivative I having a structure shown in Formula (I) and a polyethylene glycol derivative II having a structure shown in Formula (II) and has multiple “long arms”. After tannic acid and/or citric acid as a chelating agent chelates with the hydrogel skeleton, a medical hydrogel can be obtained, which has good bacteriostatic properties, mechanical properties, adhesion properties, low swelling properties, and controllable gel formation rate and degradation rate.

Abstract: A wire bonding system is provided. The wire bonding system includes a bond head assembly configured to carry a wire bonding tool; and a wire replacement system configured to (i) remove a wire portion engaged with the wire bonding tool, the wire portion being part of a wire supply on the wire bonding system, and (ii) to replace the wire portion to be engaged with the wire bonding tool.

Abstract: A wire bonding system is provided. The wire bonding system includes (i) a bond head assembly configured to carry a wire bonding tool; and (il) a wire bonding tool replacement system for replacement of the wire bonding tool with another wire bonding tool.

Abstract: A production method for a bispecific antibody, comprising constructing cells for producing a bispecific antibody, screening the cells, culturing the cells obtained in step one to obtain a culture solution, and performing separation and purification to obtain the bispecific antibody. The cells comprise CHO cells. The culture mode comprises fed-batch culture or perfusion culture. Various influence factors in fermentation culture and separation and purification are comprehensively analyzed, and by effective control, all factors can effectively cooperate, so that a high-purity bispecific antibody is efficiently produced, the daily output can reach 3 g/L or above, and the purity of the purified bispecific antibody can reach 90% or above. Moreover, the production process is amplified and verified, the process is stable and reliable, the cost is low, a great breakthrough is achieved compared with an existing production method.

Abstract: The present disclosure belongs to the field of biomedical materials, and specifically relates to a medical tissue adhesive, and a preparation method therefor and the use thereof, and a composition and a kit for preparing the medical tissue adhesive. According to the medical tissue adhesive provided by the present disclosure, a three-dimensional net-shaped gel skeleton structure is formed by means of the mutual crosslinking of a polyethylene glycol derivative L a polyethylene glycol derivative H and trilysine. Moreover, the gel skeleton has a crosslinked network density and intermolecular interaction that can be improved, and accordingly has an improved structure bonding strength and mechanical strength.

Abstract: The present disclosure relates a modified SIS membrane for tissue repair, a preparation method therefor and a use thereof. Specifically provided are a composition comprising a fusion polypeptide-modified SIS membrane and an extracellular vesicle, as well as a preparation method for and a use of the composition. It is proved that the fusion polypeptide-mediated SIS membrane and the composition containing the SIS membrane and the extracellular vesicle have excellent biological functions, and provide a broad prospect for treating bone defects or facilitating tissue healing or bone regeneration.

Abstract: In view of the shortcomings of low tissue adhesiveness or low tissue compliance and the problems of about low operability and inadequate convenience and portability of current tissue sealing materials, the present application provides an absorbable biological patch with self-adhesiveness, comprising a substrate layer and an adhesive coating located on the substrate layer, wherein the substrate layer is a biological material, and the adhesive coating is a succinimidyl ester group-grafted polyacrylic crosslinked copolymer, and optionally comprises a biodegradable polymer. The biological patch can be adhered firmly to the tissue surface and applied directly without extra preparation, and has good biocompatibility, has biodegradability, and can be used in common clinical scenarios such as tissue adherence, wound hemostasis, and low-pressure leakage of body fluids.

Abstract: In view of the problems of inadequate adhesiveness, low operability, and inadequate convenience and portability of current tissue sealing materials, the present disclosure provides a PEG bicomponent self-adhesive absorbable biological patch, comprising a substrate layer and an adhesive coating located on the substrate layer, wherein the substrate layer is a biological material, and the adhesive coating is a hydrogel formed by a bicomponent of polyethylene glycol succinimidyl ester and polyethylene glycol amine at a specific ratio. The biological patch can be adhered firmly to the tissue surface and applied directly without extra preparation, and has good biocompatibility, has biodegradability, and can be used in common clinical scenarios such as tissue adherence, wound hemostasis, and low-pressure leakage of body fluids.

Abstract: A component for a vehicle interior is disclosed; a method for producing the component is also disclosed. The component comprises a base and a cover comprising an exterior surface providing the visible surface and an interior surface; the visible surface at the cover may comprise a display operated by light source/panel configured to present an image at an image presentation area. The image presentation area may comprise a formed image presentation area; the formed image presentation area may comprise at least one formed hole formation segment comprising at least one formed hole formation based on a hole pattern segment for a pattern image area. The image presentation area of the cover may comprise each formed hole formation comprising formed hole formation segments; each formed hole formation may comprise an opening through the cover generally corresponding to a hole of the hole pattern segment.

Abstract: The present disclosure pertains to the field of biomedical materials, and in particular relates to a medical hydrogel, a preparation method and uses thereof, and a kit for preparing the medical hydrogel. The medical hydrogel of the present disclosure comprises a hydrogel skeleton, and a chelating agent chelated to the hydrogel skeleton; wherein the hydrogel skeleton comprises a polymer that is formed by the bonding of a polyethylene glycol derivative I having a structure shown in Formula (I) and a polyethylene glycol derivative II having a structure shown in Formula (II) and has multiple “long arms”. After tannic acid and/or citric acid as a chelating agent chelates with the hydrogel skeleton, a medical hydrogel can be obtained, which has good bacteriostatic properties, mechanical properties, adhesion properties, low swelling properties, and controllable gel formation rate and degradation rate.

Abstract: This application provides a multilayer printed circuit board (PCB). There is a pad array on a surface of the multilayer PCB. The pad array includes at least one padding unit, and each padding unit includes a first pad and a second pad that are adjacent. Both the first pad and the second pad are connected to a first Z-directed transmission line located in a Z-directed groove. In this way, to wire a signal wire on a signal layer of the multilayer PCB, a quantity of Z-directed grooves that need to be bypassed is less than a quantity of vias that need to be bypassed in the prior art. In other words, wiring of the signal wire is easier to some extent. In addition, this application further provides a corresponding communications device.

Abstract: This application provides a multilayer printed circuit board (PCB). There is a pad array on a surface of the multilayer PCB. The pad array includes at least one padding unit, and each padding unit includes a first pad and a second pad that are adjacent. Both the first pad and the second pad are connected to a first Z-directed transmission line located in a Z-directed groove. In this way, to wire a signal wire on a signal layer of the multilayer PCB, a quantity of Z-directed grooves that need to be bypassed is less than a quantity of vias that need to be bypassed in the prior art. In other words, wiring of the signal wire is easier to some extent. In addition, this application further provides a corresponding communications device.

Abstract: An image forming apparatus includes an image forming unit configured to start image formation in accordance with a second job while performing the image formation in accordance with a first job, each of the first job and the second job including information indicating one of paper feeding units; a detecting unit configured to detect whether a recording medium is stored in a paper feeding unit indicated by the first job; and an image formation control unit configured to cause the image forming unit to continue the image formation in accordance with the second job when the detecting unit detects that a recording medium is stored in the paper feeding unit, and cause the image forming unit to suspend the image formation in accordance with the second job when the detecting unit detects that no recording medium is stored in the paper feeding unit.

Abstract: An image forming apparatus includes an image forming unit configured to start image formation in accordance with a second job while performing the image formation in accordance with a first job, each of the first job and the second job including information indicating one of paper feeding units; a detecting unit configured to detect whether a recording medium is stored in a paper feeding unit indicated by the first job; and an image formation control unit configured to cause the image forming unit to continue the image formation in accordance with the second job when the detecting unit detects that a recording medium is stored in the paper feeding unit, and cause the image forming unit to suspend the image formation in accordance with the second job when the detecting unit detects that no recording medium is stored in the paper feeding unit.

Abstract: The present invention relates to methodology for polymer grafting by a polysaccharide synthase and, more particularly, polymer grafting using the hyaluronate or chondroitin or heparin/heparosan synthases from Pasteurella multocida, in order to create a variety of glycosaminoglycan oligosaccharides having a natural or chimeric or hybrid sugar structure.

Abstract: The present invention relates to methodology for polymer grafting by a polysaccharide synthase and, more particularly, polymer grafting using the hyaluronate or chondroitin or heparin/heparosan synthases from Pasteurella, in order to create a variety of glycosaminoglycan oligosaccharides having a natural or chimeric or hybrid sugar structure with a targeted size that are substantially monodisperse in size.